IPO Adda With Glenmark Life Sciences' MD & CEO Yasir Rawjee

Glenmark Life Sciences aims to raise Rs 1,500 crore at price band of Rs 695 - Rs 710 per share. What is company's business strategy and growth projections? In conversation with MD & CEO Yasir Rawjee. #BQLive